Dysphagia Cafe Blog

Continuing EducationInternational

Rinki Varindani Desai, M.S.CCC-SLPMarch 20, 2016

Top Takeaways from Dysphagia Research Society 2016

AdvocacyPodcasts

Dysphagia CafeMarch 11, 2016

5 questions for dysphagia clinicians: Asked and answered

Pediatric

Dysphagia CafeMarch 8, 2016

Pediatric Anatomy-Pop Quiz!

AdvocacyContinuing EducationInstrumental AssessmentPodcasts

Dysphagia CafeFebruary 18, 2016

Not all swallowing clinicians have access to instrumental examinations…

Coffee Break

Dysphagia CafeFebruary 4, 2016

Dysphagia Cafe March Madness Bracket Challenge #DysphagiacafeMM2016

AdvocacyPediatric

Dysphagia CafeFebruary 4, 2016

Free Downloads-Chewing can be tricky: Keeping children safer at mealtime

Coffee BreakContinuing Education

Dysphagia CafeJanuary 31, 2016

9 Dysphagia resources for the speech-language pathologists

Art & ScienceAssessmentTreatment

Pamela Smith, Ph.D. CCC-SLPJanuary 27, 2016

Passionately dispassionate practice: Split personality vs. Clinical necessity

AssessmentNeurogenic DysphagiaTreatment

Mary Spremulli, MA,CCC-SLPJanuary 20, 2016

Parkinson’s Disease and dysphagia: Timing matters

AssessmentHead Neck CancerTreatment

Emily Poole MA, CCC-SLPJanuary 6, 2016

Dysphagia in Total Laryngectomy

Interpreting Oral Phase Signals That Shape Swallow Performance: What Clinicians Need to Know

Applying and Integrating Outside the Box Thinking for Chronic Swallowing Disorders in the Outpatient Setting

Advancing Speech Pathology Care in the Trauma Population

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.

Type To Search